Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-14 Purchase | 2024-11-18 7:20 pm | Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director | 20,000 | $3.7 | $74,000 | 31,250 (Direct) | View |
| 2024-11-06 Sale | 2024-11-08 7:24 pm | Tango Therapeutics Inc. | TNGX | EcoR1 Capital LLC 10% Owner | 2,700,000 | $3.1243 | $8,435,743 | 10,630,736 (Indirect) | View |
| 2024-11-06 Sale | 2024-11-07 9:30 pm | Tango Therapeutics Inc. | TNGX | Boxer Capital Management LLC Davis Aaron I. See remarks | 3,080,000 | $3.14 | $9,671,200 | 10,707,885 (Indirect) | View |
| 2024-10-25 Sale | 2024-10-28 06:59 am | Tango Therapeutics Inc. | TNGX | Boxer Capital Management LLC Davis Aaron I. See remarks. | 633,000 | $6.87 | $4,348,710 | 13,787,885 (Indirect Direct) | View |
| 2024-10-21 Sale | 2024-10-23 9:31 pm | Tango Therapeutics Inc. | TNGX | Boxer Capital Management LLC Davis Aaron I. See remarks | 875,000 | $6.9729 | $6,101,250 | 14,420,885 (Indirect Direct) | View |
| 2024-09-13 Sale | 2024-09-17 4:48 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 67,400 | $10.53 | $709,756 | 16,859,075 (Direct) | View |
| 2024-09-05 Sale | 2024-09-09 7:19 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 75,000 | $11.56 | $867,135 | 16,926,475 (Direct) | View |
| 2024-08-30 Sale | 2024-09-04 8:42 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 175,000 | $11.6 | $2,029,703 | 17,001,475 (Direct) | View |
| 2024-08-27 Sale | 2024-08-29 4:40 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 25,000 | $11.55 | $288,665 | 17,176,475 (Direct) | View |
| 2024-08-16 Sale | 2024-08-20 5:59 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 285,000 | $9.9487 | $2,835,368 | 17,201,475 (Direct) | View |
| 2024-07-30 Sale | 2024-08-01 5:51 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 235,000 | $9.8574 | $2,316,494 | 17,486,475 (Direct) | View |
| 2024-07-26 Sale | 2024-07-30 4:15 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 50,000 | $9.839 | $491,950 | 17,721,475 (Direct) | View |
| 2024-07-24 Sale | 2024-07-26 4:15 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 300,599 | $9.8335 | $2,955,931 | 17,771,475 (Direct) | View |
| 2024-07-22 Sale | 2024-07-24 4:15 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 387,740 | $9.7835 | $3,793,446 | 18,072,074 (Direct) | View |
| 2024-07-18 Sale | 2024-07-22 4:15 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 191,490 | $9.8098 | $1,878,479 | 18,459,814 (Direct) | View |
| 2024-07-17 Sale | 2024-07-18 4:15 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 550,171 | $9.7903 | $5,386,339 | 18,651,304 (Direct) | View |
| 2024-06-28 Sale | 2024-07-02 8:56 pm | Tango Therapeutics Inc. | TNGX | MVA Investors LLC Davis Aaron I. See remarks | 234,731 | $8.756 | $2,055,314 | 108,793 (Direct) | View |
| 2024-06-06 Sale | 2024-06-07 9:14 pm | Tango Therapeutics Inc. | TNGX | MVA Investors LLC Davis Aaron I. See remarks | 140,000 | $7.042 | $985,880 | 348,524 (Indirect Direct) | View |
| 2024-06-05 Sale | 2024-06-07 5:16 pm | Tango Therapeutics Inc. | TNGX | Calhoun Lesley Ann Director | 5,000 | $7.2078 | $36,039 | 43,750 (Direct) | View |
| 2024-05-01 Sale | 2024-05-03 9:34 pm | Tango Therapeutics Inc. | TNGX | MVA Investors LLC Davis Aaron I. See remarks | 210,000 | $7.5279 | $1,580,850 | 488,524 (Indirect) | View |
| 2024-02-20 Sale | 2024-02-21 5:52 pm | Tango Therapeutics Inc. | TNGX | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner | 162,500 | $12 | $1,950,000 | 19,201,475 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 9:14 pm | Tango Therapeutics Inc. | TNGX | Weber Barbara Chief Executive Officer | 9,138 | $12.59 | $115,052 | 1,535,167 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 9:09 pm | Tango Therapeutics Inc. | TNGX | Barry Douglas General Counsel | 2,776 | $12.59 | $34,951 | 43,981 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 9:08 pm | Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer | 3,725 | $12.59 | $46,900 | 132,397 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 9:04 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 8,371 | $12.59 | $105,395 | 119,478 (Direct) | View |
| 2023-11-01 Sale | 2023-11-02 4:49 pm | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 7,507 | $8.3914 | $62,994 | 81,250 (Direct) | View |
| 2023-10-13 Purchase(A) | 2023-10-17 7:41 pm | Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Davis Aaron I. LEWIS JOSEPH MVA Investors LLC Boxer Asset Management Inc. See remarks | 1,250,000 | $6.978 | $8,722,500 | 15,912,577 (Indirect Direct) | View |
| 2023-10-13 Purchase | 2023-10-17 6:04 pm | Tango Therapeutics Inc. | TNGX | Boxer Capital LLC Davis Aaron I. LEWIS JOSEPH MVA Investors LLC Boxer Asset Management Inc. See remarks | 1,250,000 | $6.978 | $8,722,500 | 15,912,577 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-10-22 8:48 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | Boxer Capital Management LLC See remarks. | 0 | $0 | 10,539,221 (Indirect) | View |
| 2024-09-03 Other | 2024-09-05 9:01 pm | N/A 2034-09-03 | Tango Therapeutics Inc. | TNGX | Davis Aaron I. See remarks. | 65,000 | $0 | 65,000 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:21 pm | N/A 2034-06-05 | Tango Therapeutics Inc. | TNGX | Peters Malte Director | 43,750 | $0 | 48,750 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:17 pm | N/A 2034-06-05 | Tango Therapeutics Inc. | TNGX | Rothenberg Mace Director | 43,750 | $0 | 48,750 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:16 pm | N/A 2034-06-05 | Tango Therapeutics Inc. | TNGX | Calhoun Lesley Ann Director | 43,750 | $0 | 43,750 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:13 pm | N/A 2034-06-05 | Tango Therapeutics Inc. | TNGX | Ketchum John B Director | 32,812 | $0 | 42,812 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 5:11 pm | N/A 2034-06-05 | Tango Therapeutics Inc. | TNGX | Borisy Alexis Director | 43,750 | $0 | 48,750 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:27 pm | N/A 2034-02-01 | Tango Therapeutics Inc. | TNGX | Beckman Daniella Chief Financial Officer | 275,888 | $0 | 275,888 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:22 pm | N/A 2034-02-01 | Tango Therapeutics Inc. | TNGX | Crystal Adam See Remarks | 326,192 | $0 | 326,192 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:21 pm | N/A 2034-02-01 | Tango Therapeutics Inc. | TNGX | Weber Barbara Chief Executive Officer | 610,180 | $0 | 610,180 (Direct) | View |
| 2024-02-01 Option Award | 2024-02-05 4:19 pm | N/A 2034-02-01 | Tango Therapeutics Inc. | TNGX | Barry Douglas General Counsel | 160,015 | $0 | 160,015 (Direct) | View |
Ownership | 2023-10-16 3:42 pm | N/A N/A | Tango Therapeutics Inc. | TNGX | EcoR1 Capital LLC 10% Owner | 0 | $0 | 13,330,736 (Indirect) | View |